BRNS · Barinthus Biotherapeutics plc.
$0.57
+0.00 (+0.65%)
At close · Jul 29
Market Cap
$23.44M
Shares
40.85M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-02 | 2026-06-30 | |
| DEF 14A | 2026-06-10 | 2026-07-02 | |
| 8-K | 2026-05-21 | 2026-05-20 | |
| 8-K | 2026-04-30 | — | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-03-31 | 2026-03-27 | |
| 10-K | 2026-03-13 | 2025-12-31 | |
| 8-K | 2026-03-13 | — | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-01-06 | 2025-12-30 | |
| 8-K | 2025-12-10 | — | |
| 8-K | 2025-11-07 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-09-30 | 2025-09-29 | |
| 8-K/A | 2025-08-08 | 2025-08-07 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-10 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | 2025-05-01 | |
| DEF 14A | 2025-04-25 | 2025-06-10 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-11-25 | — | |
| 8-K | 2024-11-15 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-09-05 | 2024-09-01 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-12 | — | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-05-15 | 2024-05-10 | |
| 8-K/A | 2024-05-14 | 2024-05-13 | |
| 8-K | 2024-05-13 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-04-18 | — | |
| DEF 14A | 2024-03-22 | 2024-05-10 | |
| 8-K | 2024-03-20 | — | |
| 10-K | 2024-03-20 | 2023-12-31 | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2023-12-22 | 2023-12-20 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-11-06 | — | |
| DEF 14A | 2023-10-05 | 2023-11-06 | |
| 8-K | 2023-08-10 | — |
Showing 1–50 of 84 filings